Tag: af (atrial fibrillation)

Using AI, Mobile ECG Aims to Expand QTc Screening Horizons

Mobile electrocardiography (mECG) devices can go places a standard 12-lead electrocardiography system can’t, with fewer technicians in tow, but it doesn’t have the same functionality...

Curious Variation in AF Incidence, Mortality Across Europe

The prevalence of atrial fibrillation (AF) and its related mortality have been holding fairly steady in Europe overall during the past 3 decades, but a...

First Experience With Completely Leadless CRT

Totally leadless cardiac resynchronization therapy (CRT) combining the Micra transcatheter pacing system and a WiSE-CRT system was feasible and associated with significant acute QRS reduction...

Digoxin a ‘Viable Alternative’ in AF With HF: RATE-AF Published

A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker...

Biomarker May Flag Response to Novel AF Intervention

Neuropeptide Y (NPY), a sympathetic cotransmitter, might provide a clue to which patients with atrial fibrillation (AF) will respond to vagal nerve stimulation to decrease AF...

New-Onset AF Common But Unrecognized Early After Cardiac Surgery

One in five patients at elevated stroke risk who underwent cardiac surgery with no history of atrial fibrillation preoperatively or at discharge developed postoperative AFib...

Rivaroxaban Rivals Warfarin in AF, Mitral Bioprosthesis

The direct oral anticoagulants (DOACs) took cardiology by storm a decade ago when trials showed they were at least as safe and effective as warfarin...

No Secondary Prevention Benefit With Omega-3s in Elderly

Omega-3 fatty acids on top of standard care did not reduce major cardiovascular events or death in elderly survivors of an acute myocardial infarction (MI)...

STRENGTH Trial Questions CV Benefit of High-Dose Omega-3s

Questions about the cardiovascular benefit of omega-3 fatty acids and the high-dose eicosapentaenoic acid (EPA) product, icosapent ethyl (Vascepa, Amarin), have resurfaced with the presentation...

Omega-3, Vit-D Both Fail at AF Primary Prevention in VITAL-Rhythm

Clinical trials of omega-3 fatty acid or vitamin D supplements have followed a long and winding road in search of benefits in cardiovascular (CV) disease,...

Study Questions Routine Long-term Beta-Blocker Post MI

Current American and European guidelines recommending long-term beta-blocker therapy following an acute MI appear to be obsolete in the modern reperfusion era, suggests an analysis...

‘Cautious’ DOAC Underdosing in AF May Push Mortality Higher

The risk for death goes up for patients with atrial fibrillation (AF) who are put on direct oral anticoagulants (DOAC) at dosages other than those...

‘Low-Risk’ Valvular AF in Some May Warrant Oral Anticoagulation

Some patients with “valvular” atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic...

New ESC/EACTS Guideline on Atrial Fibrillation

New atrial fibrillation management guidelines from the European Society of Cardiology (ESC) call for diagnostic confirmation and structured characterization of AF and the need to...

RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF

Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent atrial fibrillation and symptoms of heart failure,...

Early Rhythm Control in AF Gains New Life

Initiation of rhythm control with antiarrhythmic drugs and/or ablation in patients with early, recently diagnosed atrial fibrillation led to a significantly lower risk for major...

A Tenuous Step Forward for Pulsed Field Ablation in Persistent AF

Pulsed field ablation (PFA) targeting areas beyond the pulmonary vein appeared to provide short-term lesion control without esophageal injury in persistent atrial fibrillation (AF) in...

ESC 2020 Looks to Make its Mark in ‘New Era’ of Virtual Meetings

The coronavirus may have quashed plans to socialize and stroll the canals of Amsterdam while at this year’s European Society of Cardiology (ESC) Congress, but...

Cooling Device Limits Esophageal Lesions From AF Ablations

Repurposing a device meant to cool patients after surviving a cardiac arrest allows cardiologists to minimize esophageal injury during radio frequency ablation for atrial fibrillation...

Some Post-TAVR Arrhythmias Likely Present Pre-TAVR but Go Undetected

In a prospective study of 106 patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis, 48.1% were found to have preexisting arrhythmias on...

For Some, Sacubitril/Valsartan May Obviate Need for ICD

After 6 months of therapy with the combination drug sacubitril/valsartan (S/V; Entresto, Novartis), one quarter of primary prevention patients with left heart failure and an...

DOACs Linked to Lower Fracture Risk vs Warfarin in AFib Patients

Among patients with atrial fibrillation, use of direct oral anticoagulants is linked to lower osteoporotic fracture risk versus warfarin, results of a recent population-based cohort study...

Leadless Pacemaker Shown Safe in Older, Sicker Patients

A leadless right-ventricular pacemaker continued to show an edge over conventional transvenous pacemakers by triggering a substantially reduced rate of complications during the 6 months...

Time to Switch From TSH to T4 for Assessment of Thyroid Function?

When assessing thyroid function, thyroid hormone levels ― particularly free thyroxine (FT4) levels ― consistently show stronger associations with a wide array of clinical conditions...

Atrial Fibrosis Link to ESUS Questions Stroke-AF Connection

What if atrial fibrillation (AF) turned out to be a marker of risk for cardioembolic stroke but not necessarily the direct cause of culprit thrombi?...